- Home
- ADAP vs FNWB Comparison
ADAP vs FNWB Comparison
Compare ADAP & FNWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- FNWB
- Stock Information
- Founded
- ADAP 2008
- FNWB 1923
- Country
- ADAP United Kingdom
- FNWB United States
- Employees
- ADAP N/A
- FNWB N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- FNWB Banks
- Sector
- ADAP Health Care
- FNWB Finance
- Exchange
- ADAP Nasdaq
- FNWB Nasdaq
- Market Cap
- ADAP 75.5M
- FNWB 79.5M
- IPO Year
- ADAP 2015
- FNWB 2015
- Fundamental
- Price
- ADAP $0.08
- FNWB $7.59
- Analyst Decision
- ADAP Hold
- FNWB Hold
- Analyst Count
- ADAP 6
- FNWB 1
- Target Price
- ADAP $1.02
- FNWB $12.00
- AVG Volume (30 Days)
- ADAP 18.4M
- FNWB 16.1K
- Earning Date
- ADAP 08-11-2025
- FNWB 07-24-2025
- Dividend Yield
- ADAP N/A
- FNWB 3.70%
- EPS Growth
- ADAP N/A
- FNWB N/A
- EPS
- ADAP N/A
- FNWB N/A
- Revenue
- ADAP $179,639,000.00
- FNWB $49,473,000.00
- Revenue This Year
- ADAP N/A
- FNWB $35.06
- Revenue Next Year
- ADAP $38.72
- FNWB $13.06
- P/E Ratio
- ADAP N/A
- FNWB N/A
- Revenue Growth
- ADAP 878.53
- FNWB N/A
- 52 Week Low
- ADAP $0.08
- FNWB $6.05
- 52 Week High
- ADAP $1.36
- FNWB $12.10
- Technical
- Relative Strength Index (RSI)
- ADAP 25.83
- FNWB 40.34
- Support Level
- ADAP $0.08
- FNWB $7.66
- Resistance Level
- ADAP $0.36
- FNWB $7.94
- Average True Range (ATR)
- ADAP 0.02
- FNWB 0.24
- MACD
- ADAP -0.02
- FNWB -0.00
- Stochastic Oscillator
- ADAP 1.38
- FNWB 10.14
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.